Home › Funds › Stonepine Capital Management, LLC › BSX

Stonepine Capital Management, LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Stonepine Capital Management, LLC reported holding 55,000 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 1.84% of its reported portfolio and ranking #15 among its reported holdings. Stonepine Capital Management, LLC has disclosed BSX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)55.00K sh
Reported value held$2.40M
Portfolio Weight1.84%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's BSX position evolved

Stonepine Capital Management, LLC first disclosed a stake in BSX in Q2 2026 at 50,000 shares (US$3.2M). Across 2 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 55,000 shares valued at US$2.4M — an increase of 5,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 50.00K $3.25M New
Q3 2026 55.00K $2.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Stonepine Capital Management, LLC held BSX?

Stonepine Capital Management, LLC has disclosed BSX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Stonepine Capital Management, LLC's current position in BSX?

As of Q3 2026, Stonepine Capital Management, LLC holds 55.00K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $2.40M, representing 1.84% of its reported portfolio and ranking #15.

Has Stonepine Capital Management, LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in BSX.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.